Please assess the completion status of the following clinical trial:

Trial Title: Extensive Staging in Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
1. Patients undergoing examinations on suspicion of lung cancer (both SCLC and NSCLC) at St. Olavs Hospital~2. Potentially curable disease at the referral time (Stage I-III, based on the first CT)~3. Age ≥ 18 years~4. ECOG Performance 0-2~5. No serious concomitant disorders (for example marked reduced respiratory capacity, active infection, unstable cardiovascular disease, renal dysfunction) that in the opinion of the investigator would compromise the patient's ability to complete the study or interfere with the evaluation of the efficacy and safety of the study procedure~6. No contraindication for study specific procedure - bronchoscopy, CT, MRI and PET.~7. No conditions - medical, social, psychological - which could prevent adequate information and follow-up~8. No pregnancy or lactating women~9. Written informed consent

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard diagnostic work-up (Type: NO_INTERVENTION): All patients will undergo todays' standard work-up (examination for diagnosing and staging) of lung cancer. This will be individualized for each patient according to current guidelines.
- Extensive diagnostic work-up (Type: EXPERIMENTAL): All patients will in addition to standard diagnostic work-up undergo PET-MRI and systematic mediastinal and hilar lymph node mapping using EBUS-TBNA (endobronchial ultrasound transbronchial needle aspiration of lymph nodes).

Based on this trial design, predict the completion outcome and termination type (if applicable).